Go Pro
NASDAQ:KMTS

Kestra Medical Technologies Q1 2026 Earnings Report

Kestra Medical Technologies logo
$25.76 +0.25 (+0.98%)
Closing price 09/24/2026 04:00 PM Eastern
Extended Trading
$25.79 +0.03 (+0.12%)
As of 09/24/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Kestra Medical Technologies EPS Results

Actual EPS
-$0.50
Consensus EPS
-$0.66
Beat/Miss
Beat by +$0.16
One Year Ago EPS
N/A

Kestra Medical Technologies Revenue Results

Actual Revenue
$19.37 million
Expected Revenue
$17.68 million
Beat/Miss
Beat by +$1.69 million
YoY Revenue Growth
N/A

Kestra Medical Technologies Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Thursday, September 11, 2025
Conference Call Time
7:00AM ET

Conference Call Resources

Kestra Medical Technologies Earnings Headlines

Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
See More Kestra Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Kestra Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kestra Medical Technologies and other key companies, straight to your email.

About Kestra Medical Technologies

Kestra Medical Technologies (NASDAQ:KMTS), Inc. is a medical device company focused on developing and commercializing technologies for patients at risk of sudden cardiac arrest. The company’s primary product is the ASSURE wearable cardioverter defibrillator, a wearable system designed to continuously monitor a patient’s heart rhythm and deliver an electrical shock when a life-threatening arrhythmia is detected.

The ASSURE system is intended to provide temporary protection for patients who may be at elevated risk of sudden cardiac death but are not yet candidates for, or are awaiting, an implantable cardioverter-defibrillator. The product combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable platform that can be used outside a hospital setting.

Kestra Medical Technologies serves the cardiac-care market through relationships with physicians, hospitals and other healthcare providers. The company is headquartered in the United States and focuses on advancing wearable technologies intended to support remote patient care and improve protection for individuals vulnerable to serious cardiac arrhythmias.

View Kestra Medical Technologies Profile